Risk factors for early death or euthanasia within 100 days of diagnosis in dogs with meningoencephalitis of unknown origin

Meningoencephalitis of unknown origin (MUO) in the dog is an inflammatory condition of the central nervous system with variable short- and long-term prognosis. Previous studies have attempted to identify risk factors for early death; however, the findings were inconsistent and prognostication and tr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The veterinary journal (1997) 2022-09, Vol.287, p.105884-105884, Article 105884
Hauptverfasser: Lawn, R.W., Harcourt-Brown, T.R.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 105884
container_issue
container_start_page 105884
container_title The veterinary journal (1997)
container_volume 287
creator Lawn, R.W.
Harcourt-Brown, T.R.
description Meningoencephalitis of unknown origin (MUO) in the dog is an inflammatory condition of the central nervous system with variable short- and long-term prognosis. Previous studies have attempted to identify risk factors for early death; however, the findings were inconsistent and prognostication and treatment selection remain difficult for cases of MUO. The aim of this study was to compare the influence of putative prognostic factors on early survival in dogs with MUO. Logistic regression was used to analyse the effect of clinical and magnetic resonance imaging (MRI) features at diagnosis and type of immune-suppressive treatment received on survival at three-time points; 7 days, 30 days, and 100 days post-diagnosis. Ninety eight dogs were included. Dogs that were obtunded at presentation had a 6.6 times increased odds of death in the first 7 days after diagnosis, a 2.1 times increased risk of death 8-30 days after diagnosis, and a 1.9 times increased risk of death 31-100 days after diagnosis. No other clinical, MRI feature, or treatment was found to have a significant influence on survival. Obtundation at presentation was found to increase risk of early euthanasia in dogs with MUO, while the addition of an IV infusion of cytarabine to immune-suppressive corticosteroid therapy (prednisolone and / or dexamethasone) at initial treatment did not improve the odds of survival at 7, 30, or 100 days after diagnosis. •Clinical records of dogs with meningoencephalitis of unknown origin were reviewed•Obtundation at presentation increased the odds of early death up to 6.6-fold•Association between obtundation and mortality reduced over time•A treatment protocol including intravenous cytarabine did not improve survival
doi_str_mv 10.1016/j.tvjl.2022.105884
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2704868787</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1090023322000995</els_id><sourcerecordid>2704868787</sourcerecordid><originalsourceid>FETCH-LOGICAL-c263t-4052ec07c8a977a6486cfd9ebabbeee34be0e179924fefd239dc30811ff5d9743</originalsourceid><addsrcrecordid>eNp9kE9LKzEUxQdR0Kd-AVdZupl6k5k2E3Aj4ntPEATRdUiTm_bWaVKTVKmf3hnr2tX9d86B-6uqCw4TDnx2tZqU91U_ESDEsJh2XXtQnfBpI2qhJD8celBQg2ia4-pPzisAUG0rTqrPJ8qvzBtbYsrMx8TQpH7HHJqyZOO4LUsTTCbDPqgsKTAOwJzZZRY9c2QWIWbKbDi4uMjfIrbGQGERMVjcLE1Phb7V2_Aa4kcYYmlB4aw68qbPeP5TT6uXv3fPt__rh8d_97c3D7UVs6bULUwFWpC2M0pKM2u7mfVO4dzM54jYtHME5FIp0Xr0TjTK2QY6zr2fOiXb5rS63OduUnzbYi56Tdli35uAcZu1kDBkdrKTg1TspTbFnBN6vUm0NmmnOegRtF7pEbQeQes96MF0vTfh8MQ7YdLZ0vi6o4S2aBfpN_sXMJCJbw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2704868787</pqid></control><display><type>article</type><title>Risk factors for early death or euthanasia within 100 days of diagnosis in dogs with meningoencephalitis of unknown origin</title><source>Access via ScienceDirect (Elsevier)</source><creator>Lawn, R.W. ; Harcourt-Brown, T.R.</creator><creatorcontrib>Lawn, R.W. ; Harcourt-Brown, T.R.</creatorcontrib><description>Meningoencephalitis of unknown origin (MUO) in the dog is an inflammatory condition of the central nervous system with variable short- and long-term prognosis. Previous studies have attempted to identify risk factors for early death; however, the findings were inconsistent and prognostication and treatment selection remain difficult for cases of MUO. The aim of this study was to compare the influence of putative prognostic factors on early survival in dogs with MUO. Logistic regression was used to analyse the effect of clinical and magnetic resonance imaging (MRI) features at diagnosis and type of immune-suppressive treatment received on survival at three-time points; 7 days, 30 days, and 100 days post-diagnosis. Ninety eight dogs were included. Dogs that were obtunded at presentation had a 6.6 times increased odds of death in the first 7 days after diagnosis, a 2.1 times increased risk of death 8-30 days after diagnosis, and a 1.9 times increased risk of death 31-100 days after diagnosis. No other clinical, MRI feature, or treatment was found to have a significant influence on survival. Obtundation at presentation was found to increase risk of early euthanasia in dogs with MUO, while the addition of an IV infusion of cytarabine to immune-suppressive corticosteroid therapy (prednisolone and / or dexamethasone) at initial treatment did not improve the odds of survival at 7, 30, or 100 days after diagnosis. •Clinical records of dogs with meningoencephalitis of unknown origin were reviewed•Obtundation at presentation increased the odds of early death up to 6.6-fold•Association between obtundation and mortality reduced over time•A treatment protocol including intravenous cytarabine did not improve survival</description><identifier>ISSN: 1090-0233</identifier><identifier>EISSN: 1532-2971</identifier><identifier>DOI: 10.1016/j.tvjl.2022.105884</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><subject>Canine ; Death ; Meningoencephalitis of unknown origin ; Obtundation ; Risk factors</subject><ispartof>The veterinary journal (1997), 2022-09, Vol.287, p.105884-105884, Article 105884</ispartof><rights>2022</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c263t-4052ec07c8a977a6486cfd9ebabbeee34be0e179924fefd239dc30811ff5d9743</citedby><cites>FETCH-LOGICAL-c263t-4052ec07c8a977a6486cfd9ebabbeee34be0e179924fefd239dc30811ff5d9743</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids></links><search><creatorcontrib>Lawn, R.W.</creatorcontrib><creatorcontrib>Harcourt-Brown, T.R.</creatorcontrib><title>Risk factors for early death or euthanasia within 100 days of diagnosis in dogs with meningoencephalitis of unknown origin</title><title>The veterinary journal (1997)</title><description>Meningoencephalitis of unknown origin (MUO) in the dog is an inflammatory condition of the central nervous system with variable short- and long-term prognosis. Previous studies have attempted to identify risk factors for early death; however, the findings were inconsistent and prognostication and treatment selection remain difficult for cases of MUO. The aim of this study was to compare the influence of putative prognostic factors on early survival in dogs with MUO. Logistic regression was used to analyse the effect of clinical and magnetic resonance imaging (MRI) features at diagnosis and type of immune-suppressive treatment received on survival at three-time points; 7 days, 30 days, and 100 days post-diagnosis. Ninety eight dogs were included. Dogs that were obtunded at presentation had a 6.6 times increased odds of death in the first 7 days after diagnosis, a 2.1 times increased risk of death 8-30 days after diagnosis, and a 1.9 times increased risk of death 31-100 days after diagnosis. No other clinical, MRI feature, or treatment was found to have a significant influence on survival. Obtundation at presentation was found to increase risk of early euthanasia in dogs with MUO, while the addition of an IV infusion of cytarabine to immune-suppressive corticosteroid therapy (prednisolone and / or dexamethasone) at initial treatment did not improve the odds of survival at 7, 30, or 100 days after diagnosis. •Clinical records of dogs with meningoencephalitis of unknown origin were reviewed•Obtundation at presentation increased the odds of early death up to 6.6-fold•Association between obtundation and mortality reduced over time•A treatment protocol including intravenous cytarabine did not improve survival</description><subject>Canine</subject><subject>Death</subject><subject>Meningoencephalitis of unknown origin</subject><subject>Obtundation</subject><subject>Risk factors</subject><issn>1090-0233</issn><issn>1532-2971</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kE9LKzEUxQdR0Kd-AVdZupl6k5k2E3Aj4ntPEATRdUiTm_bWaVKTVKmf3hnr2tX9d86B-6uqCw4TDnx2tZqU91U_ESDEsJh2XXtQnfBpI2qhJD8celBQg2ia4-pPzisAUG0rTqrPJ8qvzBtbYsrMx8TQpH7HHJqyZOO4LUsTTCbDPqgsKTAOwJzZZRY9c2QWIWbKbDi4uMjfIrbGQGERMVjcLE1Phb7V2_Aa4kcYYmlB4aw68qbPeP5TT6uXv3fPt__rh8d_97c3D7UVs6bULUwFWpC2M0pKM2u7mfVO4dzM54jYtHME5FIp0Xr0TjTK2QY6zr2fOiXb5rS63OduUnzbYi56Tdli35uAcZu1kDBkdrKTg1TspTbFnBN6vUm0NmmnOegRtF7pEbQeQes96MF0vTfh8MQ7YdLZ0vi6o4S2aBfpN_sXMJCJbw</recordid><startdate>202209</startdate><enddate>202209</enddate><creator>Lawn, R.W.</creator><creator>Harcourt-Brown, T.R.</creator><general>Elsevier Ltd</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202209</creationdate><title>Risk factors for early death or euthanasia within 100 days of diagnosis in dogs with meningoencephalitis of unknown origin</title><author>Lawn, R.W. ; Harcourt-Brown, T.R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c263t-4052ec07c8a977a6486cfd9ebabbeee34be0e179924fefd239dc30811ff5d9743</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Canine</topic><topic>Death</topic><topic>Meningoencephalitis of unknown origin</topic><topic>Obtundation</topic><topic>Risk factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lawn, R.W.</creatorcontrib><creatorcontrib>Harcourt-Brown, T.R.</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The veterinary journal (1997)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lawn, R.W.</au><au>Harcourt-Brown, T.R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Risk factors for early death or euthanasia within 100 days of diagnosis in dogs with meningoencephalitis of unknown origin</atitle><jtitle>The veterinary journal (1997)</jtitle><date>2022-09</date><risdate>2022</risdate><volume>287</volume><spage>105884</spage><epage>105884</epage><pages>105884-105884</pages><artnum>105884</artnum><issn>1090-0233</issn><eissn>1532-2971</eissn><abstract>Meningoencephalitis of unknown origin (MUO) in the dog is an inflammatory condition of the central nervous system with variable short- and long-term prognosis. Previous studies have attempted to identify risk factors for early death; however, the findings were inconsistent and prognostication and treatment selection remain difficult for cases of MUO. The aim of this study was to compare the influence of putative prognostic factors on early survival in dogs with MUO. Logistic regression was used to analyse the effect of clinical and magnetic resonance imaging (MRI) features at diagnosis and type of immune-suppressive treatment received on survival at three-time points; 7 days, 30 days, and 100 days post-diagnosis. Ninety eight dogs were included. Dogs that were obtunded at presentation had a 6.6 times increased odds of death in the first 7 days after diagnosis, a 2.1 times increased risk of death 8-30 days after diagnosis, and a 1.9 times increased risk of death 31-100 days after diagnosis. No other clinical, MRI feature, or treatment was found to have a significant influence on survival. Obtundation at presentation was found to increase risk of early euthanasia in dogs with MUO, while the addition of an IV infusion of cytarabine to immune-suppressive corticosteroid therapy (prednisolone and / or dexamethasone) at initial treatment did not improve the odds of survival at 7, 30, or 100 days after diagnosis. •Clinical records of dogs with meningoencephalitis of unknown origin were reviewed•Obtundation at presentation increased the odds of early death up to 6.6-fold•Association between obtundation and mortality reduced over time•A treatment protocol including intravenous cytarabine did not improve survival</abstract><pub>Elsevier Ltd</pub><doi>10.1016/j.tvjl.2022.105884</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1090-0233
ispartof The veterinary journal (1997), 2022-09, Vol.287, p.105884-105884, Article 105884
issn 1090-0233
1532-2971
language eng
recordid cdi_proquest_miscellaneous_2704868787
source Access via ScienceDirect (Elsevier)
subjects Canine
Death
Meningoencephalitis of unknown origin
Obtundation
Risk factors
title Risk factors for early death or euthanasia within 100 days of diagnosis in dogs with meningoencephalitis of unknown origin
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T17%3A19%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Risk%20factors%20for%20early%20death%20or%20euthanasia%20within%20100%20days%20of%20diagnosis%20in%20dogs%20with%20meningoencephalitis%20of%20unknown%20origin&rft.jtitle=The%20veterinary%20journal%20(1997)&rft.au=Lawn,%20R.W.&rft.date=2022-09&rft.volume=287&rft.spage=105884&rft.epage=105884&rft.pages=105884-105884&rft.artnum=105884&rft.issn=1090-0233&rft.eissn=1532-2971&rft_id=info:doi/10.1016/j.tvjl.2022.105884&rft_dat=%3Cproquest_cross%3E2704868787%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2704868787&rft_id=info:pmid/&rft_els_id=S1090023322000995&rfr_iscdi=true